Contents of this document
- FY2025 operating profit¥729 million
- Increase in gross profit¥710 million
- Increase in SG&A expenses (excluding share acquisition costs and M&A amortization)¥-385 million
- Share acquisition costs (MedMarge)¥-23 million
- Increase in M&A-related amortization and other expenses¥-33 million
- FY2026 operating income¥998 million
- Confectionery and bakery: growth in B2B, private-label products, and average order value
- Professional beauty and healthcare: revenue growth is planned, while profit is expected to decline due to upfront investment
- IT and human resources: assess the impact of the shift to AI and prioritize profitability and stable utilization over scale
- Launch of the DX support service Urico
- Launch of the healthcare support service “Salocri”
- Development of a data platform, business automation, and use of generative AI leveraging AI and DX
- Launch of the human resources placement business in FY2027
- Operation of the cotta STORE OIMACHI TRACKS store
- B2B private-label sales mix45 %
- Number of B2B orders295 thousand transactions
- B2C private-label sales mix55.8 %
- Professional beauty private-label sales mix17.6 %Year on year against the same period last year+1.6pt
- IT and human resources personnel deployed150 people approx.
- ROIC10.7 %Year on year against the same period last year+0.7pt
- B2B average order value for confectionery and bakery products14,704 yen
- Number of B2B orders for confectionery and bakery products295 thousand transactions
- Active professional beauty customers3.2 10,000 companies
- Fourth-quarter average order value in professional beauty18,150 yen
- Average billing rate for IT and human resources756,059 yen per person-month
- Gross profit per person in IT and human resources125,562 yen
- Confectionery and bakingNet Sales9,452Revenue Unit¥ millionYear-on-year sales3.8Business profit779Profit Unit¥ millionYear-on-year change in profit12.9
- Professional Beauty and HealthcareNet Sales4,916Revenue Unit¥ millionYear-on-year sales44.5Business profit328Profit Unit¥ millionYear-on-year change in profit134.9
- IT and Human ResourcesNet Sales1,412Revenue Unit¥ millionYear-on-year sales21.4Business profit95Profit Unit¥ millionYear-on-year change in profit35.5
| Item | Details |
|---|---|
| Document type | Earnings presentation materials |
| Fiscal Period Covered | Full year ended September 2026 |
| Net Sales | ¥15,781 million (YoY +15.4%) |
| Operating profit | ¥998 million (YoY +37.0%) |
| Ordinary income | ¥976 million (YoY +34.1%) |
| Net income | ¥540 million (net profit attributable to owners of the parent) (YoY +29.5%) |
| Gross Profit Margin | 30.2 % |
| Operating profit margin | 6.3 % |
| Selling, general and administrative expenses | ¥3,774 million |
| Results for the three months of the current quarter | Metrics for the standalone fourth quarter of FY2026, including B2B average order value, active customers, and average order value and active customers in the professional beauty wholesale business |
| Full-year earnings forecast | Net Sales ¥16,410 million / Gross profit ¥5,058 million / Selling, general and administrative expenses ¥4,054 million / Operating profit ¥1,003 million / Profit attributable to owners of the parent ¥618 million / Business profit ¥1,227 million |
| Self-assessment against the plan | Revenue and operating profit exceeded the upwardly revised budget. Net income attributable to owners of the parent fell below the upwardly revised budget. |
| Segment results | Segment Confectionery and baking / Net Sales 9,452 / Revenue Unit ¥ million / Year-on-year sales 3.8 / Business profit 779 / Profit Unit ¥ million / Year-on-year change in profit 12.9, Segment Professional Beauty and Healthcare / Net Sales 4,916 / Revenue Unit ¥ million / Year-on-year sales 44.5 / Business profit 328 / Profit Unit ¥ million / Year-on-year change in profit 134.9, Segment IT and Human Resources / Net Sales 1,412 / Revenue Unit ¥ million / Year-on-year sales 21.4 / Business profit 95 / Profit Unit ¥ million / Year-on-year change in profit 35.5 |
| Breakdown of Factors Affecting the Change | Item FY2025 operating profit / Amount ¥729 million, Item Increase in gross profit / Amount ¥710 million, Item Increase in SG&A expenses (excluding share acquisition costs and M&A amortization) / Amount ¥-385 million, Item Share acquisition costs (MedMarge) / Amount ¥-23 million, Item Increase in M&A-related amortization and other expenses / Amount ¥-33 million, Item FY2026 operating income / Amount ¥998 million |
| Key KPIs | Indicator B2B private-label sales mix / Value 45 % / Year on year against the same period last year Not disclosed, Indicator Number of B2B orders / Value 295 thousand transactions / Year on year against the same period last year Not disclosed, Indicator B2C private-label sales mix / Value 55.8 % / Year on year against the same period last year Not disclosed, Indicator Professional beauty private-label sales mix / Value 17.6 % / Year on year against the same period last year +1.6pt, Indicator IT and human resources personnel deployed / Value 150 people (approx.) / Year on year against the same period last year Not disclosed, Indicator ROIC / Value 10.7 % / Year on year against the same period last year +0.7pt |
| Unit price and quantity metrics | Indicator B2B average order value for confectionery and bakery products / Value 14,704 yen, Indicator Number of B2B orders for confectionery and bakery products / Value 295 thousand transactions, Indicator Active professional beauty customers / Value 3.2 10,000 companies, Indicator Fourth-quarter average order value in professional beauty / Value 18,150 yen, Indicator Average billing rate for IT and human resources / Value 756,059 yen (per person-month), Indicator Gross profit per person in IT and human resources / Value 125,562 yen |
| Number of stores and locations | Opened the cotta STORE OIMACHI TRACKS store on 28 March 2026. The number of stores at the end of the period was 1. The number of openings and closures during the period was Not disclosed. |
| Assumptions Underlying the Business Outlook | Confectionery and bakery: growth in B2B, private-label products, and average order value, Professional beauty and healthcare: revenue growth is planned, while profit is expected to decline due to upfront investment, IT and human resources: assess the impact of the shift to AI and prioritize profitability and stable utilization over scale |
| Medium-term management plan targets | Target fiscal year FY2030 / Net Sales ¥20.5 billion / Business profit ¥2.05 billion / Business profit margin 10% / Compared with FY2026 results Revenue of ¥15.781 billion, business profit of ¥1.203 billion, and a business profit margin of 7.6% |
| Financial targets | ROIC FY2026 actual: 10.7%. Maintain ROIC > cost of capital going forward / Equity ratio FY2026 actual: 46.1% |
| Annual Dividend | FY2026 ¥10 per share / FY2027 forecast ¥10 per share / Breakdown Interim and year-end breakdown: Not disclosed |
| Payout ratio | FY2026 19.6 % / DOE Target range of 2.0–2.5% |
| Capital expenditures | 104 Million yen (investment in property, plant and equipment) |
| New initiatives | Launch of the DX support service Urico, Launch of the healthcare support service “Salocri”, Development of a data platform, business automation, and use of generative AI leveraging AI and DX, Launch of the human resources placement business in FY2027, Operation of the cotta STORE OIMACHI TRACKS store |
Items this document does not state (7)
These are items the company does not state in this document. We do not leave them blank, nor fill them in from other sources or by inference.
The reasons the company gives
The company's own explanation, not something inferred from the numbers.Profit growth was driven by revenue growth and improved gross margin in existing businesses, the extension of the WORKS Group's consolidation period from 9 months to the full year, and the consolidation of MedMarge for 5 months from May 2026. Revenue and operating profit exceeded the upwardly revised budget, but net income attributable to owners of the parent fell below it due to increases in income taxes and net income attributable to non-controlling interests.